Oseltamivir reduces transmission, morbidity, and mortality of highly pathogenic avian influenza in chickens

International Congress Series

Volumn 1263, Issue C, 2004, Pages 495-498

  Meijer, Adam ^a   van der Goot, Jeanet A ^b   Koch, Guus ^b   van Boven, Michiel ^b   Kimman, Tjeerd G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antiviral prophylaxis; Antiviral treatment; Chicken; Highly pathogenic avian influenza virus; Transmission

Indexed keywords

EID: 84870580624     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.01.020     Document Type: Article

References (7)

1. Alexander, D.J., Brown, I.H., Recent zoonoses caused by influenza A viruses. Rev. Sci. Tech. 19 (2000), 197–225.
2. Influenza activity—United States, 2001–02 season. MMWR Morb. Mortal. Wkly. Rep. 52 (2003), 224–225.
3. Koopmans, M, et al. Update on human infections with highly pathogenic avian influenza virus A/H7N7 during an outbreak in poultry in the Netherlands. Eurosurveill. Wkly., 7, 2003 030501 (http://www.eurosurveillance.org/ew/2003/030501.asp).
4. Aymard-Henry, M, et al. Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bull. World Health Organ. 48 (1973), 199–202.
5. van der Goot, J.A., et al. Comparison of the transmission characteristics of low and high pathogenicity avian influenza A virus (H5N2). Epidemiol. Infect. 130 (2003), 1003–1013.
6. Gubareva, L.V., Penn, C.R., Webster, R.G., Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 212 (1995), 323–330.
7. Leneva, I.A., et al. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals. Antimicrob. Agents Chemother. 45 (2001), 1216–1224.